Navigation Links
QLT announces interim results of radical study evaluating Visudyne combination therapy
Date:12/16/2008

Visudyne therapy is a two-step procedure involving the intravenous administration of the drug into the patient's arm. A non-thermal laser light is then shone into the patient's eye to activate the drug. This produces a reaction that closes the abnormal leaky vessels, resulting in a stabilization of the corresponding vision loss.

Visudyne is approved worldwide for the treatment of a form of wet AMD, the leading cause of legal blindness in people over the age of 50, and has been used in more than two million treatments worldwide. Visudyne is commercially available in more than 80 countries for the treatment of predominantly classic subfoveal CNV. In addition, over 60 countries have approved Visudyne to treat other macular neovascular conditions such as minimally classic and occult with no classic AMD lesions, pathologic myopia and presumed ocular histoplasmosis.

Visudyne is generally well tolerated and has a well established safety profile. The most commonly reported side effects include injection site reactions and visual disturbances. In addition, some patients experienced back pain, usually during the infusion. Using the approved light dose of 50J/cm2 between 1% and 5% of patients experienced a substantial decrease in vision in the first 7 days with partial recovery in some patients. Recent studies suggest that halving the light dose/fluence may lower the incidence of visual disturbances with similar visual outcomes as the standard light dose which led to lower light doses being used in this study. After treatment, patients should avoid direct sunlight for five days to prevent sunburn. People with porphyria should not be treated with Visudyne.

About QLT

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the field of ophthalmology. In additio
'/>"/>

SOURCE QLT Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pets Best Announces New Underwriter for Pet Insurance Policies
2. Lilly Announces Dividend Increase
3. Anthem Blue Cross and Blue Shield and Summerlin Life and Health Insurance Company Enter Into Endorsement Agreement as Summerlin Announces Exit From the Commercial PPO Business in Nevada
4. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
5. Musculoskeletal Transplant Foundation Announces Major Development Milestone in Stem Cell Allograft Product
6. DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with Previously Reported Investigation
7. Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
8. Alfacell Announces Management Update
9. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
10. Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
11. Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 The ... as well as a number of specific concerns within, ... stigma reduction and mental health in the workplace. We ... mental health. The campaign also brings special focus to ... individuals to speak up and seek help from healthcare ...
(Date:5/29/2015)... Ca (PRWEB) May 29, 2015 ... pain consultations with specialists, physical therapy, and injections ... experiencing mid back and/or lower back pain, Healthpointe ... epidural injections for herniated discs, disc protrusions and ... . , Healthpointe’s team of renowned surgeons ...
(Date:5/29/2015)... 2015 The Global Allopurinol Industry ... on the current state of the Allopurinol industry.With ... statistics on the state of the industry and ... for companies and individuals interested in the market. ... industry including definitions, classifications, applications and industry chain ...
(Date:5/29/2015)... Florida (PRWEB) May 29, 2015 Designed ... Bodybuilding.com teamed up to create an all new, exclusive ... are a formulated with the latest and greatest, high ... and proven to be effective. The 24/7 Series can ... to cross-fitters and even the casual fitness enthusiasts. There ...
(Date:5/29/2015)... Javlin continues to fulfill its worldwide growth ... larger team, with the intention to better serve the ... the U.S. and Canada. , Javlin Inc., the wholly ... in 2014 with its strongest earnings to date, based ... CloverETL. To accelerate further progress and ensure exceptional customer ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2
... Workers Seeking Ground Rules for Union Election Say Hospital System Fails ... ... 27 Hundreds of faith leaders,elected officials and other community members ... and procession outside the,system,s headquarters on Saturday, where they called for ...
... Discussed at American Society of Plastic Surgeons Annual ... ... fact or fiction, non- and minimally-invasive techniques to,remove fat are making headlines. ... surgery? Plastic surgeons will discuss if,these are cutting edge new discoveries or ...
... 27 The American Red Cross,Blood Services national system ... into southern California to help stabilize the blood,supply in ... Red Cross has provided nearly 2,000 blood products to ... Blood Services Region.,Blood drives in southern California have been ...
... 8 and 9, 2007, PENSACOLA, Fla., Oct. ... to be a major sponsor for this Summit. ... in,healthcare, the Department of Defense, Veterans Administration, research,organizations ... solutions,for strategic health intelligence. This summit represents the ...
... WITH ... , http://www.mccormickandschmicks.com/index.cfm?fuseaction=content.display Adult-Care.Org, Inc. ... to promote Better Choice, Healthy Food and a Healthy ... reach a new generation of consumers., PORTLAND, Ore., Oct. ...
... of Estrostep Fe Under TriLegest(TM) Fe ... ... Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its subsidiary, ... (FDA) for its Abbreviated New Drug Application (ANDA) to,manufacture and market ...
Cached Medicine News:Health News:Healthcare Workers to St. Joseph Health System: Fair Election Agreement Now 2Health News:Non-Invasive Fat-Melting Procedures - Hype or Reality? 2Health News:American Red Cross Blood Services Supports Blood Needs of Southern California 2Health News:Cogon Systems Supports the Pensacola Bay Area Chamber of Commerce with the Strategic Health Intelligence Summit 2Health News:Barr's Generic Version of Estrostep(R) Fe Tablets Approved 2Health News:Barr's Generic Version of Estrostep(R) Fe Tablets Approved 3Health News:Barr's Generic Version of Estrostep(R) Fe Tablets Approved 4
(Date:5/29/2015)...  Dr. Yair Walzer has added a leading ... often caused by menopause. The MonaLisa Touch™, an in-office procedure ... clearance in 2014. Dr. Walzer is one of the first ... special fractional CO 2 laser specifically designed to help ... In 2010 there were greater than 46M women between ...
(Date:5/29/2015)... 2015 LifeNet Health plans to enlarge its ... to more than 160 people. The organization,s ... Health,s innovative bio-implants, which are being made more widely ... served. It also is a reflection of the region,s ... growth and success of LifeNet Health is a great ...
(Date:5/29/2015)... and MENLO PARK, Calif. ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and ... and commercializing proven cancer therapies in new orphan ... American Association of Cancer Research (AACR) Advances ... potential for its lead product candidate VAL-083 ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2LifeNet Health to add more than 160 jobs in 2015 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5
... 6, 2010 The Novartis Pharmaceutical Corporation ("Novartis") ... control and tumor reduction in extensively pretreated Hodgkin ... refractory after an autologous stem cell transplant, according ... trial presented today(1). In this pivotal ...
... 2010 Direct Relief International announced ... medical supplies to assist cholera patients in Haiti. The products ... JUH is the main public hospital for the entire northern ... also be distributed to the numerous cholera treatment units (CTUs) ...
Cached Medicine Technology:Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 2Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 3Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 4Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 5Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 6Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients 7CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti 2CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti 3
... EC 350 consists of two modular units. ... surface and reaches a temperature of -15C. ... reservoir, heated dispenser nozzle, heated work surface, ... separate heated compartments for molds and cassettes. ...
... The exclusive mountant media dispensing ... air bubbles under the coverglass. ... interface with most automated staining ... to load, pre-filled coverglass and ...
... robotic system for spinal procedures. The SpineAssist ... highly accurate, easy-to-use solution that enables surgery ... minimum intervention. SpineAssist currently answers a growing ... guidance devices in pedicle screw insertion for ...
Hydrophobic Acrylic Intraocular Lens, AC depth: 5.3....
Medicine Products: